CAS 145022-92-0

Tauro-β-muricholic acid sodium

CAS: 145022-92-0

Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM).

Fórmula: C₂₆H₄₄NNaO₇S

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 537.69

Ref: TM-T13093

β-Tauromuricholic-d5 Acid

CAS: 145022-92-0, 25696-60-0

Fórmula: C₂₆H₄₀D₅NO₇S

Peso molecular: 520.74

Ref: 4Z-C-5778

Tauro-beta-muricholic Acid Sodium Salt

Produto Controlado

CAS: 145022-92-0

Stability Hygroscopic
Applications Tauro-β-muricholic Acid Sodium Salt is the salt form of Tauro-α-muricholic Acid which is a bile acid released by the liver and is typically used in cholestasis studies.
References Yang, L. et al.: Chem. Res. Toxicol., 21, 2280 (2008); Holm, R. et al.: Phys. Chem. Chem. Phys., 11, 5070 (2009);

Fórmula: C₂₆H₄₄NO₇S·Na

Cor e Forma: Neat

Peso molecular: 537.68

Ref: TR-T009135

Tauro-β-muricholic acid sodium

CAS: 145022-92-0

Tauro-β-muricholic acid sodium is a bile acid derivative, which is naturally sourced from mammalian bile. It plays a crucial role in the regulation of bile acid metabolism by modulating the activity of nuclear receptors in the liver and intestine. This compound acts by inhibiting farnesoid X receptor (FXR) signaling, a nuclear receptor that regulates bile acid synthesis, lipid metabolism, and glucose homeostasis. By influencing these pathways, Tauro-β-muricholic acid sodium is an important tool for scientists studying liver function, cholesterol metabolism, and intestinal microbiome interactions.

Fórmula: C₂₆H₄₄NNaO₇S

Pureza: Min. 95%

Peso molecular: 537.7 g/mol

Ref: 3D-VFA02292